SCM
EW icon

Sirios Capital Management’s Edwards Lifesciences EW Stock Holding History

Sirios Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-390,642
Closed -$9.26M – 54
2015
Q3 		$9.26M Buy
390,642
+270,642
+226% +$6.53M 0.3% 49
2015
Q2 		$2.85M Buy
+120,000
New +$2.71M 0.09% 53

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Sirios Capital Management's EW Position: Q4 2015 in Review

Sirios Capital Management sold out of Edwards Lifesciences (EW) in Q4 2015, closing a stake of 390,642 shares — an estimated $9.26M sold.

Sirios Capital Management first reported a position in EW in Q2 2015 and held it in 2 quarters. The position peaked at $9.26M in Q3 2015. 605 funds tracked by Wall St. Rank hold EW as of Q4 2015.

  • Sirios Capital Management reported no remaining Edwards Lifesciences position as of Q4 2015 after selling out during the quarter.
  • Sirios Capital Management sold 390,642 Edwards Lifesciences shares in Q4 2015, an estimated $9.26M.
  • Sirios Capital Management first reported a position in Edwards Lifesciences in Q2 2015 and held it in 2 quarters.
  • Sirios Capital Management's Edwards Lifesciences position peaked at $9.26M in Q3 2015.
  • 605 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2015.

Based on Sirios Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.